Impact of programmatic intervention on the treatment compliance of patients with HIV/TB dual infection

To study the treatment compliance impact of Programmatic intervention to acquired immune deficiency syndrome (AIDS) patients with Mycobacterium tuberculosis (TB) dual infection. 90 cases HIV/TB dual infection patients were selected and randomly divided into the observation group (n=45) and the control group (n=45). The observation group was treated after the programmatic interventions, whereas the control group followed the conventional treatment. CD4+ T lymphocyte level, treatment compliance and adverse reaction were compared between two groups after four months intervention. After 4 months treatment, the rate of patients with CD4+ lymphocyte >350/mu l (60% vs. 6.67%, P<0.05), medication compliance (91.11% vs. 66.67%, P<0.05), dietary compliance (82.22% vs. 57.78%, P<0.05) and inspection compliance (73.33% vs. 42.22%, P<0.05) were significantly higher in the observation group than that in control group. Whereas the rate of patients with CD4+ lymphocyte <300/mu l (6.67% vs. 22.22%, P<0.05) and adverse reaction (17.78% vs. 60%, P<0.05) in the observation group were markedly lower. Programmatic intervention on patients with HIV/TB dual infection can improve the patients' treatment compliance and CD4+ T lymphocyte levels. It is worth popularized in clinic to improve life quality.